About Laurus Synthesis
Laurus Synthesis is a Healthcare company based in Woburn (United States) founded in 2006. It offers CDMO services for APIs, intermediates, and key starting materials. It operates on a B2B model. The company has 211 employees. Its Indian entity Laurus Synthesis Private Limited reported revenue of ₹498 Cr. Its focus areas include Pharmaceuticals, Manufacturing and CDMO Services.
Company details
Laurus Synthesis offers cdmo services for apis, intermediates, and key starting materials through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and cdmo services. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Woburn, United States
- Employees 211
- SectorsHealthcare
- Email••••••••
- Website laurussynthesis.com
- Social LinkedIn X Facebook
- Legal Name Laurus Synthesis Private Limited
- Date of Incorporation 18 May, 2020
- Jurisdiction Hyderabad, Telangana, India
- Indian entity revenue₹498 Cr
FY 2026 · +108% YoY
- Indian entity net profit₹76.53 Cr
FY 2026 · 15% margin
- Indian entity EBITDA₹245 Cr
FY 2026 · 49% margin
- Employee Count211
Associated legal entities of Laurus Synthesis
Laurus Synthesis is associated with 2 registered companies on The Company Check; the primary company is Laurus Synthesis Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Laurus Synthesis Private Limited CIN U24110AP2020PTC121364 | Active | 18 May 2020 | Anakapalle, Andhra Pradesh | ₹498 Cr | 211 | 5 | View details |
| Laurus Synthesis Private Limited CIN U24110TG2020PTC140333 | 18 May 2020 | Hyderabad, Telangana, India | View details |
Board of directors of Laurus Synthesis Private Limited (Laurus Synthesis)
Laurus Synthesis Private Limited is the primary company behind Laurus Synthesis. The board of Laurus Synthesis Private Limited currently have 5 directors; the longest-serving is Sita Ramaiah Chagarlamudi, appointed in 2020. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sita Ramaiah Chagarlamudi DIN 08210856 | Director | 18 May 2020 | 6 yrs 5 mo | Laurus Synthesis Private Limited |
| Krishna Chaitanya Chava DIN 06831883 | Director | 18 May 2020 | 6 yrs 5 mo | Laurus Synthesis Private Limited |
| Venkata Lakshmi Narasimha Rao Dammalapati DIN 03258307 | Director | 23 Jul 2020 | 6 yrs 3 mo | Laurus Synthesis Private Limited |
| Narasimha Rao Chava DIN 08836445 | Director | 17 Aug 2020 | 6 yrs 2 mo | Laurus Synthesis Private Limited |
| Soumya Chava DIN 06831892 | Director | 22 Jul 2021 | 5 yrs 3 mo | Laurus Synthesis Private Limited |
People of Laurus Synthesis
1 people are tracked at Laurus Synthesis (1 in leadership); the tracked headcount is 211.
| Name | Role | Group |
|---|---|---|
Andrew Badrot | CEO | Leadership |
Complete people profiles for Laurus Synthesis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Laurus Synthesis
Figures of Laurus Synthesis Private Limited, the primary company behind Laurus Synthesis, for FY 2026. Revenue was ₹498 Cr (+108% year on year). Net profit was ₹76.53 Cr (15% margin). EBITDA was ₹245 Cr (49% margin). Revenue has grown at a compounded annual rate of +66% over three years and +100% over five years.
- ₹498 CrRevenue · FY 2026 · +108% YoY
- ₹76.53 CrNet profit · 15% margin
- ₹245 CrEBITDA · 49% margin
- ₹10.8 LakhPaid-up capital
- 211Employees (provident fund records)
- +66%Revenue CAGR, 3 years
- +100%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Laurus Synthesis Private Limited are on its company page.
Detailed financial statements for Laurus Synthesis
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as Laurus Synthesis (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 61.16 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Laurus Synthesis
Complete news archive for Laurus Synthesis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Laurus Synthesis
Laurus Synthesis was founded in 2006.
Laurus Synthesis is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Laurus Synthesis has 211 employees.
The primary company behind Laurus Synthesis, Laurus Synthesis Private Limited, reported revenue of ₹498 Cr for FY 2026, up 108% year on year.
Laurus Synthesis offers cdmo services for apis, intermediates, and key starting materials through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and cdmo services. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Laurus Synthesis operates through Laurus Synthesis Private Limited.
The legal entities of Laurus Synthesis currently have 5 directors, including Sita Ramaiah Chagarlamudi, Venkata Lakshmi Narasimha Rao Dammalapati, Soumya Chava and others.